AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05611398 — intervention group
Intervention type: PROCEDURE
Intervention: Orthopedic Surgery
Description: A complete retrospective chart review was performed for all the patients' records and included all patients aged 18 years or higher who presented to Arrowhead Regional Medical Center with long bone fractures with Injury Severity Score \<16 and their repair and lactate levels at the time of surgery
Study NCT05000060 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Timing/1 week
Description: Time of restart of antiplatelet therapy is one week after injury
Study NCT05000060 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Timing/3 weeks
Description: Time of restart of antiplatelet therapy is left to treating clinician discretion
Study NCT06498999 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 4-STEP-Training Program for Social Media Addiction (4-STEP-TPS)
Description: 4 Modules with 1 Module being delivered in 1 weekly session of approximately 90 minutes. The details of each module/step is described as follows:~Step 1 (Module 1): S = Screening, Assessment and Psychoeducation: Involves screening and assessment of the problem, interpretation of the results, feedback and psychoeducation, identifying and breaking the resistance, motivation, and conceptualization.~Step 2 (Module 2): T = Treatment Conceptualization and Planning: Involves pattern identification, distortion identification, as well as pattern and distortions modifications.~Step 3 (Module 3): E = Effective Management Strategies: Involves management strategies to treat the earlier identified patterns as well as the implementation and confirmation of activities via a Pattern Schedule Chart.~Step 4 (Module 4): P = Prevention (Lapse-Relapse): Involves self-reflection and support building, monitoring and dependency check and slip plans and support additions
Study NCT05641753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evolocumab Cartridge
Description: Injectable PCSK9 inhibitor.
Study NCT05641753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin Calcium Tablets
Description: HMG-CoA reductase inhibitor for oral use.
Study NCT05641753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ezetimibe Tablets
Description: Will only be distributed to patients with statin intolerance; replacement for both Atorvastatin and Evolocumab. Inhibitor of intestinal cholesterol for oral use.
Study NCT05641753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-FDG
Description: Optional procedure. Positron emission tomography (PET) and computed tomography (CT) imaging to assess vascular inflammation and related anatomy requires injection of the PET tracer 18F-FDG. 18F-FDG is an FDA-approved analogue of sugar, routinely used to evaluate elevated metabolism in tissues, including increased metabolism due to inflammatory cells. A standard dose of 7.0 mSv will be administered.
Study NCT05641753 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Angiocatheter 20IV
Description: Optional procedure (endothelial cell harvesting). An angiocatheter ≤ 21 gauge will be inserted into a peripheral vein on the upper extremity using aseptic technique. A 0.018in. diameter J-shaped wire (Arrow, Reading, PA) will be then advanced into the angiocatheter, to a distance of 4cm beyond the end of the angiocatheter.
Study NCT05641753 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: J-Wire
Description: Optional procedure (endothelial cell harvesting). Either a 0.021in. diameter J-shaped wire (Daig, Minnetonka, MN) or a 0.018in. diameter J-shaped wire (Arrow, Reading, PA) will be used.
Study NCT05641753 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GlycoCheck Glycocalyx Measurement Software
Description: Optional procedure (assessment of vascular function). Video microscope developed by GlycoCheck.
Study NCT04932551 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: physicians will participate in the questionnaire via WeChat. The questionnaire included six main items: physician demographic characteristics, awareness, diagnosis, medical prescription, assessment/education, and proposal.
Study NCT05568381 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: digital CBT-I
Description: Sleepio is a digital cognitive behavioral therapy (CBT) program designed to treat insomnia. The program is fully automated, and its underlying algorithms drive the delivery of information, support, and advice.
Study NCT05568381 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Online Sleep Health Education package
Description: Wait-listed control participants will have full access to three online modules for the duration of the study. The information in these modules will provide non-tailored basic sleep information and content will contain text and basic images but will not be personalised to the individual participant.
Study NCT05167318 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: frequent standardized oral care
Description: Standardized oral care will be provided every 3-4 hours
Study NCT04808492 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CureWave High Intensity Laser
Description: * The participant will lie prone and the HILT will be administered in 9 symmetrical positions which cover the lumbosacral region. Dose will be 1minute per position. The dose will include:~  * Power (44 Watts)~ * Mode (continues wave)~ * Time on (60000 ms)~ * Time off (1 ms)~ * Repeats (9)~* Distance of electrode from skin will begin 10 from skin surface. The participant may or may not feel mild warmth. Should the subject report excessive warmth or discomfort the probe distance will be increased in 2 intervals until it is comfortable. The entire process will take approximately 10 minutes.~* The participant will lie prone and the Placebo treatment will consist of positioning the HILT probe over the 9 symmetrical positions for 1 minutes each however the no laser will be admitted.
Study NCT04808492 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The participant will lie prone and the NON ACTIVE HILT will be administered in 9 symmetrical positions which cover the lumbosacral region. Dose will be 1minute per position. THE LASER WILL NOT BE ACTIVE.~o Distance of electrode from skin will begin 10 from skin surface. The entire process will take approximately 10 minutes.
Study NCT06496308 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Orelabrutinib
Description: Orelabrutinib PO will be administered as per the schedule specified in the respective arm.
Study NCT06496308 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orelabrutinib
Description: Orelabrutinib PO will be administered as per the schedule specified in the respective arm.
Study NCT06496308 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Bendamustine
Description: Bendamustine IV will be administered as per the schedule specified in the respective arm.
Study NCT06496308 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Bendamustine IV will be administered as per the schedule specified in the respective arm.
Study NCT06496308 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Rituximab
Description: Rituximab IV will be administered as per the schedule specified in the respective arm.
Study NCT06496308 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab IV will be administered as per the schedule specified in the respective arm.
Study NCT06496308 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Venetoclax
Description: Venetoclax PO will be administered as per the schedule specified in the respective arm.
Study NCT05970536 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Apple vinegar or EDTA 17%
Description: Application of each chelating agent for 5 minutes for dentin conditioning followed by placement of MTA on the pulp chamber.
Study NCT05970536 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Apple vinegar or EDTA 17%
Description: Application of each chelating agent for 5 minutes for dentin conditioning followed by placement of MTA on the pulp chamber.
Study NCT05891080 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Toripalimab
Description: Specified dose on specified days.
Study NCT05891080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Specified dose on specified days.
Study NCT05891080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS004
Description: Specified dose on specified days.
Study NCT05891080 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Specified dose on specified days.
Study NCT05891080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Specified dose on specified days.
Study NCT05891080 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nab-paclitaxel
Description: Specified dose on specified days.
Study NCT05891080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Specified dose on specified days.
Study NCT05891080 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Specified dose on specified days.
Study NCT05891080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Specified dose on specified days.
Study NCT05891080 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery
Description: Patients with resectable tumor after neoadjuvant therapy will be treated with surgery.
Study NCT05891080 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Patients with resectable tumor after neoadjuvant therapy will be treated with surgery.
Study NCT04900246 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Visual Inspection
Description: The examiners will evaluate the surfaces included in the study independently and without knowledge of the results of the other examiner, after prophylaxis, using a mouth mirror and a WHO probe or Ball point. The evaluations will be carried out in a dental chair with the aid of a reflector. The teeth will be examined moist, and afterwards, they will be dried for 5 seconds with the use of a triple syringe.~For visual inspection, the International Caries Detection and Assessment System (ICDAS) evaluation system will be used. Complete ICDAS has seven categories, the first for healthy teeth (code 0) and the next two for limited enamel caries, white/brown stain (codes 1 and 2). The following two categories (codes 3 and 4) are considered to be caries that extend to the enamel without exposed dentin. And the two remaining categories (codes 5 and 6), are considered caries with exposed dentin.
Study NCT04900246 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: BWX Radiographic Assessment
Description: Participants will be radiographed with a digital X-ray device (DIOX-602, Micro Imagem, Indaiatuba, Brazil) with a regulation of 60 kV and 2 mA and exposure time of 0.10s. The technique used will be the interproximal/bitewing (BWX), with the FIT T1 Digital Sensor (external dimensions: 36.7mm x 24.3mm/sensitive area dimensions: 30.0mm x 20.0mm - 600mm²) and the sockets will be standardized with use of Han-Shin radiographic positioners (Jon, São Paulo, Brazil).
Study NCT04900246 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Assessment of the iTero Element 5D scan
Description: For scanning, the iTero 5D (Align Technology) equipment featuring NIRI Technology will be used. The Infrared Imaging Technology (NIRI) is a diagnostic tool that allows the detection of interproximal and occlusal caries in several stages, from the initial enamel caries to lesions in the amelo-dentin junction, without the use of ionizing radiation. Infrared is the region of the electromagnetic spectrum between 0.7 and 2.0 micrometers (µm). The iTero Element 5D imaging system uses wavelength light (= 850 nm) in an electromagnetic spectrum that, in interaction with the hard tooth tissue, provides additional data on its structure.
Study NCT05733949 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples
Study NCT05733949 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05733949 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo ST-SBRT
Study NCT04973202 — intervention group
Intervention type: OTHER
Intervention: Stay for alcohol detoxification
Description: Stay for alcohol detoxification : routine care.
Study NCT05822947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active manual therapy
Description: Soft tissue mobilization of the lumbar paraspinal musculature (3 to 4 minutes).
Study NCT05822947 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control manual therapy
Description: Light touch and a breathing exercise (3 to 4 minutes).
Study NCT05973500 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet
Description: Mediterranean Diet for 42 Days
Study NCT06159530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: dental implants
Description: 4 dental implants placed in the mandible according to all-on 4 concept
Study NCT06159530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: peek framework
Description: peek framework screwed to multi-unit abutments of 4-implants
Study NCT06159530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: visio-lign nano composite
Description: peek framework veneered with nano composite (visio-lign) as an occlusal material
Study NCT06159530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: zirconia crowns
Description: peek framework covered with zirconia crowns as an occlusal material
Study NCT05746312 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: healing attempt
Description: The intervention consists of pre-composed and pre-recorded guided meditations, songs, and poems that total 25 minutes in duration. The elements of the intervention were set to background music tracks that were informed by Black diasporic music traditions and anxiety reduction principles from the music therapy literature.
Study NCT05013073 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ASTHMAXcel ED Application
Description: A mobile application designed to assist patients in asthma symptom recognition, treatment best practices, and trigger identification.
Study NCT03229850 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Insulin lispro
Description: Insulin lispro will be injected into the abdomen into an area of subclinical lipohypertrophy or an area with no subclinical lipohypertrophy
Study NCT05544357 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Short set configuration resistance training
Description: Resistance training protocol with the lowest cardiovascular stress identified in the first study of the project. It can be expected to be a short set configuration protocol
Study NCT05544357 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Long set configuration resistance training
Description: Resistance training protocol with the highest cardiovascular stress identified in the first study of the project. It can be expected to be a short set configuration protocol
Study NCT06231160 — intervention group
Intervention type: PROCEDURE
Intervention: Systematic Therapy Combined With Microwave Ablation
Description: Patients with unresectable pancreatic cancer were included for laboratory examination, and quality of life and pain scores were recorded. The experimental group underwent microwave ablation first, followed by chemotherapy according to the guidelines; The control group received the same chemotherapy. Record the use of chemotherapy drugs and the occurrence of adverse events. Follow up will be conducted at 30 days, 90 days, and 180 days after chemotherapy to evaluate pancreatic function and quality of life.
Study NCT04740788 — intervention group
Intervention type: DEVICE
Intervention: Monofocal IOL
Description: Patients are already implanted with a monofocal lens
Study NCT06436508 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early mobilization protocol
Description: * Step 1 - Day 1: Bed rest, elevation of the head end to 30°~* Step 2 - Day 2: Bed rest, elevation of the head end to 60°~* Step 3 - Day 3: Bed rest, elevation of the head end to 80°~* Step 4 - Day 4: Sitting on the edge of the bed~* Step 5 - Day 5: Sitting in a chair, standing up~* Step 6 - Day 6: Walking with or without assistance~* Step 7 - Day 7: Walking with or without assistance from today
Study NCT06436508 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: During standard care, early mobilization does not take place in the intensive care unit; the patient receives only standard supportive care in bed rest.
Study NCT05942872 — intervention group
Intervention type: OTHER
Intervention: This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.
Description: This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.
Study NCT04970797 — intervention group
Intervention type: DRUG
Intervention: Xinglouchengqi decoction
Description: the composition of Xinglouchengqi decoction: 9 g raw rhubarb, 9 g mirabilite, 6 g dananxing, 30 g quangualou decoction was uniformly prepared by the pharmacy department of our hospital. Decoction form was adopted, one dose per day, one dose of 200 mL decoction, and the decoction was taken in morning and evening twice and half an hour after meals. The observation period was 5 days: from 72 hours to 7 days after onset.
Study NCT06139445 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual Lymphatic Drainage
Description: Manual lymphatic drainage (MLD), one of the components of complex decongestive physiotherapy, is a gentle massage technique with proven positive effects on lymphatic circulation. MLD can be applied to different parts of the body (e.g., arms, legs, neck, abdomen, and trunk), with a different technique for each region (stationary circle, scoop, pump, and rotary)
Study NCT06139445 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Plasebo Group
Description: random superficial touches not involved in any manual technique
Study NCT05590013 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pectointercostal and ESP block
Description: Pectointercostal plane block will apply at the 4-5. intercostal space and ESP block will apply athe T6 level bilaterally
Study NCT05590013 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pectointercostal and ESP block
Description: Pectointercostal plane block will apply at the 4-5. intercostal space and ESP block will apply athe T6 level bilaterally
Study NCT05333289 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1030
Description: Sterile liquid for injection
Study NCT05333289 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1020
Description: Sterile liquid for injection
Study NCT05333289 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: mRNA-1010
Description: Sterile liquid for injection
Study NCT05333289 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator
Description: Sterile liquid for injection
Study NCT05048784 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sotorasib
Description: Oral tablet
Study NCT06280170 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Artificial Intelligence platform for case managers
Description: Providers will have access to the Eleos Health mobile AI platform to document their case management encounters.
Study NCT05593120 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CT-FFR
Description: In the test group all patients who are eligible for CTA will undergo CTA as their default test. Those patients with any coronary stenosis 30%-90% data in at least one major epicardial vessel will be referred for CT-FFR. In patients in whom CT-FFR analysis is performed, FFR will be derived for all vessels. CT-FFR will be evaluated in a blinded fashion with a Coarse-to-Fine Subpixel algorithm for lumen contour. The data derived from this test will determine their management strategy.
Study NCT05593120 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Routine care
Description: All patients in the routine care group will be assessed according to their current conventional pathways that are based upon routine practice in Wuhan Asia Heart Hospital. The trial will encourage the routine and standard assessment and management of all patients (anticipated outcomes include ETT, stress echo, stress MR, nuclear perfusion, CTA, CT calcium, invasive CA, reassurance).
Study NCT06433869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: serplulimab
Description: Additional intraperitoneal injection of bevacizumab or rmhTNF-NC is added to the PD-1 inhibitor.
Study NCT06433869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Intraperitoneal injection of bevacizumab is added to PD-1 inhibitor or rmhTNF-NC.
Study NCT06433869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rmhTNF-NC
Description: Intraperitoneal injection of rmhTNF-NC is added to PD-1 inhibitor or bevacizumab.
Study NCT05447715 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Fruquintinib
Description: Fruquintinib sequential BEV+FOLFIRI vs. BEV+FOLFIRI sequential fruquintinib in the treatment of metastatic colorectal cancer that has failed previous fluorouracil/oxaliplatin therapy
Study NCT04831892 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moisturizer Containing Isosorbide Diesters and Colloidal Oatmeal
Description: Study lotion containing 0.1% colloidal oatmeal along with 4% HydraSynol® DOI (Isosorbide Dicaprylate) and 4% HydraSynol® IDL/(Isosorbide Disunflowerseedate)